‘Lipitor’ Category

Lipitor Side Effects | Safe Natural Alternatives VitaLife Show Episode 75

...

 

Paramount Rx Helps Consumers Achieve Added Savings on Generic Drugs in Midst of Rising Health Care Costs

 

Cary, N.C. (PRWEB) August 16, 2013

Paramount Rx, a full-service prescription benefits manager (PBM) focused on consumer-driven health care, is helping customers achieve extended costs savings on generic drugs through its prescription benefits card program. The Paramount Rx program saves consumers up to 70 percent on generic, brand-name equivalents and offers a valuable resource in the midst of rising health care costs.

Federal law grants the distribution rights to a single generic manufacturer for a six month timeframe once the patent expires on a drug. During this period, the cost savings are about 20 percent compared to the brand drug and drop considerably after that. According to the U.S. Food and Drug Administration (FDA), generic medications cost 80 to 85 percent less on average than their brand-name counterparts. Two highly-anticipated drugs scheduled to become available in generic form over the next six months include Cymbalta, used to treat depression and Niaspan, used for high triglycerides.

When discussing treatment options with a doctor, it makes sense to ask if generic medications are available to take advantage of potential cost savings, said Michael Sallusto, executive vice president of Paramount Rx.

In an effort to extend the savings on these types of generic drugs for consumers, while also offering reductions on the price of brand-name medications, Paramount Rx has developed a national discount network of over 54,000 participating pharmacies. The program is especially beneficial for the millions of Americans who are uninsured or underinsured. All FDA-approved drugs are available through the Paramount Rx program.

Providing the best discount savings through the Paramount Rx network are some of the most common types of maintenance drugs, including hypertension medications such as Norvasc, Coreg and Zestril, along with those used to treat high cholesterol like Zocor and Lipitor. These drugs typically cost between $ 2-4 per dose for brand-name and $ 0.25-0.40 per dose for the generic.

Utilizing the Paramount Rx card to receive discounts on prescriptions requires no deductibles or maximum benefit levels and no exclusions for pre-existing health conditions. The program also hosts online tools and resources to help users locate one of its participating pharmacies across the nation, research drug pricing and availability, including generic alternatives, and access mail order services.

With new federal legislation rolling out, the American healthcare system is seeing big changes. As the industry continues to evolve and attract attention across the nation, we are providing a useful tool for both employers and consumers to find more balance with savings they can count on to navigate the new landscape, Sallusto said.

For more details on the Paramount Rx prescription discount program, along with details on how consumers can achieve unparalleled cost savings for their families and even their pets, please visit http://www.paramountrx.com/.

About Paramount Rx

Paramount Rx is a full-service prescription benefits manager (PBM) focused on consumer-driven health care to help clients provide services for consumers to save money on prescription drugs. The company has tailored programs to help their customers and consumers achieve significant savings with discount prescriptions through a national network of over 54,000 participating pharmacies. For more information, visit http://www.paramountrx.com/.

###







New Study Says Statin Drugs May Fight Mesothelioma, According to Surviving Mesothelioma

 

Raleigh, NC (PRWEB) August 15, 2013

In a recent study on statins and malignant mesothelioma, Japanese researchers combined two of the most popular statin drugs, Zocor and Lipitor, with a form of vitamin E called gamma tocotrienol (y-T3). The y-T3 alone had a negative impact on mesothelioma cells, but adding the statin drugs triggered apoptosis, or programmed cell death, in the lab.

Statin+y-T3 combination induced greater cell growth inhibition more than each single treatment, the research team wrote in a summary of their findings.

Prior studies have linked low doses of statins with health benefits in breast cancer, reduced risk of ovarian cancer, and lower incidence of liver cancer. Although statin drugs and the statin+y-T3 combination have shown promise in the laboratory, they have never been tested in human patients and it may be many years before they can be used in the clinical treatment of mesothelioma.

In the recent Japanese study, the statin drugs appeared to help kill mesothelioma cells by activating caspase 3, a protein that plays a vital role in apoptosis. Like gamma tocotrienol, statin drugs are also known to inhibit cellular metabolism via the mevalonate pathway. In the laboratory, the two mechanisms together produced a synergistic effect on mesothelioma cells. The research team reached the conclusion that the combination could be useful for malignant mesothelioma therapy and functions in a complementary style.

Mesothelioma is an aggressive and treatment-resistant cancer that starts in the tissues that surround the lungs or line the abdomen. As it spreads, it can quickly inhibit the normal function of internal organs. Clinical treatment of mesothelioma typically involves a complementary combination of different therapies, which may include chemotherapy, surgery, radiotherapy or experimental treatments such as gene therapy.

The original Japanese study appears in the journal Cancer Letters. (Tuerdi, G, et al, Synergistic effect of combined treatment with gamma-tocotrienol and statin on human malignant mesothelioma cells, July 20, 2013, Cancer Letters, Epub ahead of print. (http://www.ncbi.nlm.nih.gov/pubmed/23879968)

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.







Lipitor Diabetes Lawsuit Center Website Updated by The Onder Law Firm

 

St. Louis, MO (PRWEB) August 06, 2013

The Onder Law Firm, which handles pharmaceutical and medical device cases for clients nationwide, has supplemented its Lipitor Diabetes Lawsuit Center website to provide additional information about who the firm is able to represent. Lipitor is a popular statin drug prescribed to reduce the amount of bad cholesterol in the body. It was first approved by the FDA in 1996 and went on to produce more than $ 130 billion in sales for the drug company that makes it, Pfizer, Inc., which has made Lipitor the top-selling prescription medication of all time (2/28/2012, reuters.com/article/2012/02/28/us-fda-statins-idUSTRE81R1O220120228). Lipitor is the leader among statin drugs, which are used by more than 20 million Americans today.

Statin drugs, such as Lipitor and Crestor, have been tied to an increased risk of Type 2 diabetes in all users, prompting the FDA to issue a warning regarding the use of statins and the potential for diabetes on February 28, 2012 (fda.gov/drugs/drugsafety/ucm293101.htm). The FDA statins diabetes warning referenced a number of medical studies that demonstrated the link between statin use and higher rates of diabetes in the test subjects. One study, conducted by the Womens Health Initiative and cited in the FDA statin diabetes warning, uncovered a much higher risk for women using statins to develop Type 2 diabetes, specifically post-menopausal women.

At this time, The Onder Law Firms Lipitor diabetes lawyers are only accepting female clients who were 45 years of age or older at the time they were diagnosed with diabetes, although they could have started using Lipitor at a younger age. Attorneys at The Onder Law Firm handling Lipitor diabetes claims are offering a no-cost, no-obligation case review and will represent clients in this matter on a contingency basis, with no fees or costs of any kind unless they are able to secure a settlement for their clients. The Onder Law Firm has represented thousands of Americans in lawsuits against pharmaceutical, medical device manufacturers and other multinational conglomerates in lawsuits ranging from products liability for manufacture of defective or dangerous products to deceptive advertising practices. The Onder Law Firm welcomes Lipitor and other statin lawsuit inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm

Onder, Shelton, OLeary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from Lipitor diabetes lawyers at http://www.lipitordiabeteslawsuitcenter.com







Lipitor Diabetes Lawsuit Center Website Updated by The Onder Law Firm

 

St. Louis, MO (PRWEB) August 06, 2013

The Onder Law Firm, which handles pharmaceutical and medical device cases for clients nationwide, has supplemented its Lipitor Diabetes Lawsuit Center website to provide additional information about who the firm is able to represent. Lipitor is a popular statin drug prescribed to reduce the amount of bad cholesterol in the body. It was first approved by the FDA in 1996 and went on to produce more than $ 130 billion in sales for the drug company that makes it, Pfizer, Inc., which has made Lipitor the top-selling prescription medication of all time (2/28/2012, reuters.com/article/2012/02/28/us-fda-statins-idUSTRE81R1O220120228). Lipitor is the leader among statin drugs, which are used by more than 20 million Americans today.

Statin drugs, such as Lipitor and Crestor, have been tied to an increased risk of Type 2 diabetes in all users, prompting the FDA to issue a warning regarding the use of statins and the potential for diabetes on February 28, 2012 (fda.gov/drugs/drugsafety/ucm293101.htm). The FDA statins diabetes warning referenced a number of medical studies that demonstrated the link between statin use and higher rates of diabetes in the test subjects. One study, conducted by the Womens Health Initiative and cited in the FDA statin diabetes warning, uncovered a much higher risk for women using statins to develop Type 2 diabetes, specifically post-menopausal women.

At this time, The Onder Law Firms Lipitor diabetes lawyers are only accepting female clients who were 45 years of age or older at the time they were diagnosed with diabetes, although they could have started using Lipitor at a younger age. Attorneys at The Onder Law Firm handling Lipitor diabetes claims are offering a no-cost, no-obligation case review and will represent clients in this matter on a contingency basis, with no fees or costs of any kind unless they are able to secure a settlement for their clients. The Onder Law Firm has represented thousands of Americans in lawsuits against pharmaceutical, medical device manufacturers and other multinational conglomerates in lawsuits ranging from products liability for manufacture of defective or dangerous products to deceptive advertising practices. The Onder Law Firm welcomes Lipitor and other statin lawsuit inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm

Onder, Shelton, OLeary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from Lipitor diabetes lawyers at http://www.lipitordiabeteslawsuitcenter.com